An experimental drug has shown promise in preventing emphysema in mice exposed to cigarette smoke, giving researchers new hope that they’ll soon find a way to combat one of the most stubborn, untreatable, and common killers of humans. Even though the study focuses on emphysema in mice, the researchers suggest the drug could work in people by delaying or preventing chronic obstructive pulmonary disease, which encompasses emphysema and chronic bronchitis and is the fourth most common cause of death in the United States [Science News].
The drug, called CDDO-imidazole, or CDDO-Im, works by activating a gene called Nrf2, explains study coauthor Shyam Biswal. In prior research, Biswal and colleagues found that Nrf2 works as a “master gene,” turning on genes involved in protecting the lungs from pollution and cigarette smoke. “The Nrf2 pathway is the major antioxidant and detoxifying response in the lungs. Therapies targeting this pathway need to be ...
